UP!

EBIO $3.29

EBIO target price
3.29
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-01-19 Downgrade Citigroup Inc. Buy to Neutral
2016-01-18 Downgrade Leerink Swann Outperform to Market Perform
2015-08-15 Reiterated Rating Leerink Swann Outperform $6.00 to $8.35
2015-08-13 Boost Price Target Leerink Swann $8.00
2015-05-19 Lower Price Target Leerink Swann Outperform $23.00 to $6.00
2014-03-03 Initiated Coverage Leerink Swann Outperform
2014-03-03 Initiated Coverage Cowen and Company Outperform $35.00
2014-03-03 Initiated Coverage Citigroup Inc. Buy $35.00
2016-01-19 Downgrade Citigroup Inc. Buy to Neutral
2016-01-18 Downgrade Leerink Swann Outperform to Market Perform
2015-08-15 Reiterated Rating Leerink Swann Outperform $6.00 to $8.35
2015-08-13 Boost Price Target Leerink Swann $8.00
2015-05-19 Lower Price Target Leerink Swann Outperform $23.00 to $6.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
THIRD ROCK VENTURES LP 29.75%  (4841591) AGIO / BLUE / EBIO / FMI /
JAFCO Super V3 Investment Limited Partnership 11.82%  (1923226) EBIO /
Celniker Abbie President and CEO 2.58%  (419946) DYAX / EBIO /
Boxer Capital, LLC 1.83%  (297860) EBIO / MRTX / ODT /
Flagship Ventures Fund 2007, L.P. 1.80%  (293268) AGIO / EBIO / RCPT /
LYNCH DANIEL 0.99%  (161430) BIND / BLUE / EBIO /
Furfine Eric Steven Chief Science Officer 0.21%  (34648) EBIO /
Tubridy Karen L Chief Development Officer 0.20%  (32753) AKBA / EBIO /
MCCABE JOHN J Senior Vice President, Finance 0.04%  (5930) EBIO /